Compare KRRO & RAIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KRRO | RAIL |
|---|---|---|
| Founded | 2014 | 1901 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Railroads |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 150.0M | 149.9M |
| IPO Year | 2019 | 2005 |
| Metric | KRRO | RAIL |
|---|---|---|
| Price | $14.01 | $8.22 |
| Analyst Decision | Buy | |
| Analyst Count | 12 | 0 |
| Target Price | ★ $34.80 | N/A |
| AVG Volume (30 Days) | ★ 227.5K | 217.0K |
| Earning Date | 05-06-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 134.94 |
| EPS | N/A | ★ 1.09 |
| Revenue | $6,392,000.00 | ★ $500,991,000.00 |
| Revenue This Year | N/A | $15.68 |
| Revenue Next Year | N/A | $24.67 |
| P/E Ratio | ★ N/A | $7.42 |
| Revenue Growth | ★ 181.46 | N/A |
| 52 Week Low | $5.20 | $4.31 |
| 52 Week High | $55.89 | $14.90 |
| Indicator | KRRO | RAIL |
|---|---|---|
| Relative Strength Index (RSI) | 65.53 | 32.71 |
| Support Level | $13.80 | $7.94 |
| Resistance Level | $14.96 | $10.18 |
| Average True Range (ATR) | 0.88 | 0.41 |
| MACD | 0.20 | 0.09 |
| Stochastic Oscillator | 90.36 | 56.57 |
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability. The company operates and manages its business as one reportable segment and one operating segment, which is the business of discovering, developing and commercializing therapies derived from or incorporating its RNA-editing technology.
FreightCar America Inc is a diversified manufacturer and supplier of railcars and railcar components. It designs and manufactures a variety of railcar types for transportation of bulk commodities and containerized freight products in North America. The company also provides railcar rebody and repair services, railcar conversion services, and supplies railcar parts. The company has two segments: Manufacturing and Aftermarket. The majority of the company's revenue is derived from the Manufacturing segment, which includes new railcar manufacturing, used railcar sales, and various conversions and rebodies. Geographically, it generates the maximum revenue from the United States.